Kestra Advisory Services, LLC

Position in BCRX — Biocryst Pharmaceuticals Inc

CIK 1830819 AUSTIN, TX

Position in BCRX

as of Jun 30, 2026 · filed Jul 28, 2026 Compact

Position Value

$131,100

-$18,744 QoQ

Shares Held

13,110

-16.7% QoQ

Ownership

0.005%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#233

of 316 holders

Holding Since

Sep 2022

12 quarters on record

Healthcare · as of Jun 30, 2026

Kestra Advisory Services, LLC holds $7,523,206 across 11 Drug Manufacturers - Specialty & Generic names. BCRX ranks #10 (1.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	24,414	$1,754,390
2	TEVA	Teva Pharmaceutical Industries Ltd	46,085	$1,561,359
3	VTRS	Viatris Inc	92,472	$1,468,455
4	UTHR	UNITED THERAPEUTICS Corp	1,355	$734,179
5	HIMS	Hims & Hers Health, Inc.	17,089	$592,475
6	LNTH	Lantheus Holdings, Inc.	3,926	$435,550
7	ELAN	Elanco Animal Health Inc	11,937	$293,769
8	SUPN	Supernus Pharmaceuticals, Inc.	5,224	$242,968

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$131,100	13,110	-16.7%	Shares	Sole	2026-07-28
2026-03-31	$149,844	15,740	+20.5%	Shares	Sole	2026-04-30
2025-12-31	$101,868	13,060	-0.5%	Shares	Sole	2026-02-13
2025-09-30	$99,671	13,132	+3.4%	Shares	Sole	2025-11-14
2025-06-30	$113,792	12,700	-0.1%	Shares	Sole	2025-08-15
2025-03-31	$95,362	12,715	-0.8%	Shares	Sole	2025-05-14
2024-12-31	$96,368	12,815	-31.8%	Shares	Sole	2025-02-10
2023-09-30	$132,955	18,779	-28.0%	Shares	Sole	2023-11-13
2023-06-30	$183,596	26,079	+9.0%	Shares	Sole	2023-08-11
2023-03-31	$199,567	23,929	+11.1%	Shares	Sole	2023-05-12
2022-12-31	$247,210	21,534	+50.4%	Shares	Sole	2023-01-31
2022-09-30	$180,356	14,314	—	Shares	Sole	2022-11-01
No filing history on record for this holder in this stock.